CALCIPOTRIENE
Glenmark gets USFDA nod for generic drug with 180-day exclusivityThe USFDA noted that the Mumbai-based drug firm was the first abbreviated new drug application (ANDA) applicant with a paragraph IV certifi...
Top stocks in focus on 29 December 2017Here is a list of top stocks that are likely to be in focus in today's trading session.
Lupin gets USFDA nod for generic psoriasis treatment solutionThe USFDA approval to Lupin's calcipotriene topical solution is for strength of 0.005 per cent (scalp solution), the company said in a stat...
Glenmark Pharmaceuticals gets final USFDA approval for anti-psoriasis cream CalcipotrieneThe Calcipotriene cream is the generic version of Leo Pharma A/S's Dovonex cream 0.005 per cent.
Glenmark gets tentative USFDA nod for generic psoriasis creamGlenmark said in a statement that the product is the therapeutic equivalent of Danish pharma firm Leo Pharma A/S Dovonex's topical cream of...
Load More